Letter to the AJT Editor re: Puttarajappa et al (doi:10.1111/ajt.16150)
- PMID: 32946671
- DOI: 10.1111/ajt.16308
Letter to the AJT Editor re: Puttarajappa et al (doi:10.1111/ajt.16150)
Keywords: biomarker; biopsy; clinical research/practice; editorial/personal viewpoint; kidney transplantation/nephrology; protocol biopsy; quality of care/care delivery.
Comment in
-
Author response to comments on economic analysis of subclinical rejection screening in kidney transplantation.Am J Transplant. 2021 Mar;21(3):1348-1349. doi: 10.1111/ajt.16356. Epub 2020 Oct 31. Am J Transplant. 2021. PMID: 33068499 No abstract available.
Comment on
-
Economic analysis of screening for subclinical rejection in kidney transplantation using protocol biopsies and noninvasive biomarkers.Am J Transplant. 2021 Jan;21(1):186-197. doi: 10.1111/ajt.16150. Epub 2020 Jul 15. Am J Transplant. 2021. PMID: 32558153 Free PMC article.
References
-
- Puttarajappa CM, Mehta RB, Roberts MS, Smith KJ, Hariharan S. Economic analysis of screening for subclinical rejection in kidney transplantation using protocol biopsies and noninvasive biomarkers [published online ahead of print 2020]. Am J Transplant. https://doi.org/10.1111/ajt.16150.
-
- Friedewald JJ, Kurian SM, Heilman RL, et al. Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant. Am J Transplant. 2018;19(1):98-109.
-
- Marsh CL, Kurian SM, Rice JC, et al. Application of TruGraf v1: a novel molecular biomarker for managing kidney transplant recipients with stable renal function. Transpl Proc. 2019;51(3):722-728.
-
- Bromberg JS, Brennan DC, Poggio E, et al. Biological variation of donor-derived cell-free dna in renal transplant recipients: clinical implications. J Appl Lab Med. 2017;2(3):309-321.
-
- Ahmad I. Biopsy of the transplanted kidney. Semin Intervent Radiol. 2004;21(4):275-281.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical